Martinrea International Inc. (TSX: MRE)
Canada
· Delayed Price · Currency is CAD
9.87
+0.11 (1.13%)
Nov 20, 2024, 4:00 PM EST
Martinrea International Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 5,159 | 5,340 | 4,758 | 3,784 | 3,375 | 3,864 | Upgrade
|
Revenue Growth (YoY) | -3.36% | 12.24% | 25.73% | 12.11% | -12.64% | 5.48% | Upgrade
|
Cost of Revenue | 4,174 | 4,372 | 3,940 | 3,237 | 2,784 | 3,091 | Upgrade
|
Gross Profit | 984.88 | 967.83 | 818.02 | 547.35 | 591.38 | 772.69 | Upgrade
|
Selling, General & Admin | 330.61 | 323.44 | 276.15 | 229.9 | 248.61 | 243.88 | Upgrade
|
Research & Development | 41.79 | 38.01 | 36.92 | 32.62 | 28.91 | 38.04 | Upgrade
|
Operating Expenses | 701.31 | 671.59 | 587.77 | 497.96 | 506.69 | 485.32 | Upgrade
|
Operating Income | 283.57 | 296.24 | 230.25 | 49.4 | 84.69 | 287.37 | Upgrade
|
Interest Expense | -78.72 | -80.32 | -51.84 | -32.92 | -35.77 | -38 | Upgrade
|
Earnings From Equity Investments | -3.08 | -3.56 | -5.07 | -3.92 | -2.31 | -2.01 | Upgrade
|
Currency Exchange Gain (Loss) | 6.73 | 5.15 | 8.75 | 12.55 | -6.06 | -1.11 | Upgrade
|
Other Non Operating Income (Expenses) | 0.99 | 1.5 | 0.38 | 0.83 | 0.43 | 0.57 | Upgrade
|
EBT Excluding Unusual Items | 209.49 | 219.01 | 182.47 | 25.94 | 40.98 | 246.83 | Upgrade
|
Merger & Restructuring Charges | -38.88 | -27.27 | -7.85 | -5.47 | -10.66 | -8.17 | Upgrade
|
Gain (Loss) on Sale of Investments | - | 5.27 | 4.05 | 7.8 | 0.86 | -0.25 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.29 | 1.04 | -0.13 | -0.96 | -0.54 | 0.93 | Upgrade
|
Asset Writedown | -0.9 | -0.9 | -4.49 | - | -85.78 | -18.5 | Upgrade
|
Other Unusual Items | - | - | - | 19.95 | 39.83 | 4.2 | Upgrade
|
Pretax Income | 169.43 | 197.16 | 174.05 | 47.26 | -15.31 | 225.05 | Upgrade
|
Income Tax Expense | 68.8 | 43.49 | 41.21 | 11.38 | 12.01 | 43.82 | Upgrade
|
Earnings From Continuing Operations | 100.64 | 153.67 | 132.84 | 35.88 | -27.32 | 181.22 | Upgrade
|
Net Income | 100.64 | 153.67 | 132.84 | 35.88 | -27.32 | 181.22 | Upgrade
|
Net Income to Common | 100.64 | 153.67 | 132.84 | 35.88 | -27.32 | 181.22 | Upgrade
|
Net Income Growth | -49.18% | 15.68% | 270.23% | - | - | -2.51% | Upgrade
|
Shares Outstanding (Basic) | 77 | 80 | 80 | 80 | 80 | 82 | Upgrade
|
Shares Outstanding (Diluted) | 77 | 80 | 80 | 80 | 80 | 83 | Upgrade
|
Shares Change (YoY) | -4.09% | -0.90% | -0.04% | 0.33% | -3.02% | -5.00% | Upgrade
|
EPS (Basic) | 1.31 | 1.93 | 1.65 | 0.45 | -0.34 | 2.20 | Upgrade
|
EPS (Diluted) | 1.31 | 1.93 | 1.65 | 0.45 | -0.34 | 2.19 | Upgrade
|
EPS Growth | -46.94% | 16.97% | 269.44% | - | - | 2.34% | Upgrade
|
Free Cash Flow | 207.87 | 215.81 | 61.34 | -110.2 | 66.43 | 117.54 | Upgrade
|
Free Cash Flow Per Share | 2.71 | 2.71 | 0.76 | -1.37 | 0.83 | 1.42 | Upgrade
|
Dividend Per Share | 0.200 | 0.200 | 0.200 | 0.200 | 0.200 | 0.180 | Upgrade
|
Dividend Growth | 0% | 0% | 0% | 0% | 11.11% | 9.09% | Upgrade
|
Gross Margin | 19.09% | 18.12% | 17.19% | 14.46% | 17.52% | 20.00% | Upgrade
|
Operating Margin | 5.50% | 5.55% | 4.84% | 1.31% | 2.51% | 7.44% | Upgrade
|
Profit Margin | 1.95% | 2.88% | 2.79% | 0.95% | -0.81% | 4.69% | Upgrade
|
Free Cash Flow Margin | 4.03% | 4.04% | 1.29% | -2.91% | 1.97% | 3.04% | Upgrade
|
EBITDA | 525.1 | 557.17 | 463.1 | 252.59 | 281.89 | 459.98 | Upgrade
|
EBITDA Margin | 10.18% | 10.43% | 9.73% | 6.68% | 8.35% | 11.91% | Upgrade
|
D&A For EBITDA | 241.54 | 260.93 | 232.85 | 203.19 | 197.2 | 172.61 | Upgrade
|
EBIT | 283.57 | 296.24 | 230.25 | 49.4 | 84.69 | 287.37 | Upgrade
|
EBIT Margin | 5.50% | 5.55% | 4.84% | 1.31% | 2.51% | 7.44% | Upgrade
|
Effective Tax Rate | 40.60% | 22.06% | 23.68% | 24.08% | - | 19.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.